Furthermore, dapagliflozin can suppress the overactivation of renin–angiotensin and sympathetic nervous systems and inhibit the transformation of glucose into fatty acid oxidation, which is beneficial for glucose regulation and control in T2DM patients. Here, REN is linked to type 2 diabetes mellitus.